BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6276740)

  • 1. Attempts to initiate skin tumours in mice in the 2-stage system using 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB), and benzyl chloride (BC). Report of the experiment at 10 months.
    Coombs MM
    Mutat Res; 1982; 100(1-4):403-5. PubMed ID: 6276740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity bioassay of 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC) on mouse skin: interim (7 month) report.
    Ashby J; Gaunt C; Robinson M
    Mutat Res; 1982; 100(1-4):399-401. PubMed ID: 6276739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic toxicology of 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC) as assessed by the UKEMS genotoxicity trial (1981).
    Parry JM
    Mutat Res; 1982; 100(1-4):411-6. PubMed ID: 7035897
    [No Abstract]   [Full Text] [Related]  

  • 4. 4-Chloromethylbiphenyl (4CMB), benzyl chloride (BC) and 4-hydroxymethylbiphenyl (4HMB): an evaluation of their mutagenic potential using Salmonella typhimurium.
    Jones E; Richold M
    Mutat Res; 1982; 100(1-4):49-54. PubMed ID: 7035900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 4CMB in the subcutaneous implant test.
    Longstaff E; Gaunt C
    Mutat Res; 1982; 100(1-4):395-7. PubMed ID: 6276738
    [No Abstract]   [Full Text] [Related]  

  • 6. The biological activity of 4-chloromethylbiphenyl, benzyl chloride and 4-hydroxymethylbiphenyl in 4 short-term tests for carcinogenicity. A report of an individual study in the UKEMS genotoxicity trial 1981.
    Booth SC; Mould AJ; Shaw A; Garner RC
    Mutat Res; 1983 Feb; 119(2):121-33. PubMed ID: 6338366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of 4CMB, 4HMB and BC in Saccharomyces cerevisiae JD1.
    Wilcox P; Parry JM
    Mutat Res; 1982; 100(1-4):163-8. PubMed ID: 7035887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Chloromethylbiphenyl (4CMB), benzyl chloride (BC) and 4-hydroxymethylbiphenyl (4HMB): reverse mutation tests with Salmonella typhimurium.
    Ladner A
    Mutat Res; 1982; 100(1-4):27-31. PubMed ID: 7035893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuation test data on 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC) using Salmonella typhimurium TA98 and TA100.
    Sargent AW; Regnier AP
    Mutat Res; 1982; 100(1-4):87-90. PubMed ID: 7035908
    [No Abstract]   [Full Text] [Related]  

  • 10. The induction of mitotic gene conversion in the yeast, Saccharomyces cerevisiae JD1 by 4-chloromethylbiphenyl (4CMB), benzyl chloride (BC) and 4-hydroxymethylbiphenyl (4HMB).
    Brooks TM; Gonzalez LP
    Mutat Res; 1982; 100(1-4):157-62. PubMed ID: 7035886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UKEMS trial: bacterial mutation tests of 4-chloromethylbiphenyl, 4-hydroxymethylbiphenyl, and benzyl chloride, using E. coli WP2uvrA(pKM101) and S. typhimurium TA98 and TA100.
    Venitt S; Crofton-Sleigh C; Bosworth DA
    Mutat Res; 1982; 100(1-4):39-43. PubMed ID: 7035896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BC, 4CMB and 4HMB on the mutation of V79 cells to azaguanine resistance.
    Lee CG; Webber TD
    Mutat Res; 1982; 100(1-4):245-8. PubMed ID: 6276737
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetic toxicology in fungi of 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC). Survey of the results of the U.K.E.M.S. collaborative genotoxicity trial 1981.
    Parry JM; Wilcox P
    Mutat Res; 1982; 100(1-4):185-200. PubMed ID: 6460178
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of 4-hydroxymethylbiphenyl (4HMB), 4-chloromethylbiphenyl (4CMB) and benzyl chloride (BC) using the Ames Salmonella/microsome incorporation test for mutagenicity.
    Moore WB; Chatfield SN
    Mutat Res; 1982; 100(1-4):35-8. PubMed ID: 7035895
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene.
    Slaga TJ; Bracken WM; Dresner S; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Mar; 38(3):678-81. PubMed ID: 626971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene.
    Chouroulinkov I; Gentil A; Grover PL; Sims P
    Br J Cancer; 1976 Nov; 34(5):523-32. PubMed ID: 999784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assay for mutagenic activity of 4CMB, 4HMB and BC, using the "microtitre" fluctuation test.
    Pour MS; Merrill C; Parry JM
    Mutat Res; 1982; 100(1-4):81-5. PubMed ID: 7035907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
    Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM
    Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UKEMS genotoxicity trial. A summary of the assays for skin tumour induction in mice, the subcutaneous implant test and the sebaceous gland suppression test.
    Coombs MM
    Mutat Res; 1982; 100(1-4):407-9. PubMed ID: 6276741
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of 4CMB, 4HMB and BC on SCE, chromosome aberration and point mutation in cultured Chinese hamster ovary cells.
    Phillips BJ; James TE
    Mutat Res; 1982; 100(1-4):263-9. PubMed ID: 7057758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.